Quality Assessment and Publication Bias:
We conducted a rigorous quality assessment of the included trials using the Cochrane risk of bias tool, identifying trials of moderate-to-high quality. Notably, our results remained unaffected by any potential publication bias, as demonstrated by the symmetrical distribution of studies on each side of the vertical axis in the funnel plots of the primary outcomes.